FDA approves generic EpiPen

The FDA has approved the first generic rival to EpiPen. The self-injecting device used to treat potentially life-threatening allergic reactions has faced a number of issues in recent years, including shortages and notoriously high prices. The new generic copy will be sold by Teva Pharmaceuticals. Anna Werner reports.

Categories: Health

Leave a Reply

Your email address will not be published. Required fields are marked *